| Year |
Citation |
Score |
| 2023 |
Rehrauer KJ, Cunningham CW. IUPHAR Review - Bivalent and bifunctional opioid receptor ligands as novel analgesics. Pharmacological Research. 197: 106966. PMID 37865129 DOI: 10.1016/j.phrs.2023.106966 |
0.529 |
|
| 2023 |
Olson KM, Devereaux AL, Chatterjee P, Saldaña-Shumaker SL, Shafer A, Plotkin A, Kandasamy R, MacKerell AD, Traynor JR, Cunningham CW. Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy. Frontiers in Pharmacology. 14: 1230053. PMID 37469877 DOI: 10.3389/fphar.2023.1230053 |
0.537 |
|
| 2021 |
Terashvili M, Talluri B, Palangmonthip W, Iczkowski KA, Sanvanson P, Medda BK, Banerjee B, Cunningham CW, Sengupta JN. Peripheral antinociceptive effects of a bifunctional μ and δ opioid receptor ligand in rat model of inflammatory bladder pain. Neuropharmacology. 196: 108701. PMID 34256047 DOI: 10.1016/j.neuropharm.2021.108701 |
0.41 |
|
| 2020 |
Mada S, Gerak LR, Soyer A, Maguire DR, Hu Z, Minervini V, Cunningham CW, France CP. Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist. Psychopharmacology. PMID 32820390 DOI: 10.1007/S00213-020-05638-1 |
0.526 |
|
| 2019 |
Cunningham CW, Elballa WM, Vold SU. Bifunctional opioid receptor ligands as novel analgesics. Neuropharmacology. PMID 30858102 DOI: 10.1016/j.neuropharm.2019.03.006 |
0.495 |
|
| 2018 |
Burns SM, Cunningham CW, Mercer SL. DARK Classics in Chemical Neuroscience: Fentanyl. Acs Chemical Neuroscience. PMID 29894151 DOI: 10.1021/acschemneuro.8b00174 |
0.75 |
|
| 2018 |
Devereaux AL, Mercer SL, Cunningham CW. DARK Classics in Chemical Neuroscience: Morphine. Acs Chemical Neuroscience. PMID 29757600 DOI: 10.1021/acschemneuro.8b00150 |
0.728 |
|
| 2016 |
Healy JR, Bezawada P, Griggs NW, Devereaux AL, Matsumoto RR, Traynor JR, Coop A, Cunningham CW. Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligands. Bioorganic & Medicinal Chemistry Letters. PMID 28011222 DOI: 10.1016/j.bmcl.2016.11.057 |
0.706 |
|
| 2014 |
Cunningham CW, Deschamps JR, Coop A. A One-Step Synthesis of -Bromocodide from Codeine. Journal of Pharmaceutical Sciences and Pharmacology. 1: 54-56. PMID 34584903 |
0.603 |
|
| 2014 |
Metcalf MD, Rosicky AD, Hassan HE, Eddington ND, Coop A, Cunningham CW, Mercer SL. Opioids and efflux transporters. Part 4: influence of N-substitution on P-glycoprotein substrate activity of noroxymorphone analogues. Bioorganic & Medicinal Chemistry Letters. 24: 3592-5. PMID 24915880 DOI: 10.1016/J.Bmcl.2014.05.033 |
0.78 |
|
| 2014 |
Cunningham CW, Deschamps JR, Coop A. A One-Step Synthesis of -Bromocodide from Codeine Journal of Pharmaceutical Sciences and Pharmacology. 1: 54-56. DOI: 10.1166/jpsp.2014.1005 |
0.442 |
|
| 2013 |
Motel WC, Coop A, Cunningham CW. Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease. Mini Reviews in Medicinal Chemistry. 13: 456-66. PMID 22931533 DOI: 10.2174/138955713804999784 |
0.651 |
|
| 2011 |
Cunningham CW, Rothman RB, Prisinzano TE. Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A. Pharmacological Reviews. 63: 316-47. PMID 21444610 DOI: 10.1124/Pr.110.003244 |
0.682 |
|
| 2011 |
Lozama A, Cunningham CW, Caspers MJ, Douglas JT, Dersch CM, Rothman RB, Prisinzano TE. Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin A. Journal of Natural Products. 74: 718-26. PMID 21338114 DOI: 10.1021/Np1007872 |
0.736 |
|
| 2010 |
Cunningham CW, Hom K, Acharya C, Wilks A, Mackerell AD, Coop A. Synthesis and Characterization of a Novel Diels - Alder Adduct of Codeine. Helvetica Chimica Acta. 93: 220-226. PMID 23378668 DOI: 10.1002/Hlca.200900234 |
0.544 |
|
| 2010 |
Cunningham CW, Mukhopadhyay A, Lushington GH, Blagg BS, Prisinzano TE, Krise JP. Uptake, distribution and diffusivity of reactive fluorophores in cells: implications toward target identification. Molecular Pharmaceutics. 7: 1301-10. PMID 20557111 DOI: 10.1021/Mp100089K |
0.505 |
|
| 2009 |
Lovell KM, Simpson DS, Cunningham CW, Prisinzano TE. Utilizing nature as a source of new probes for opioid pharmacology. Future Medicinal Chemistry. 1: 285-301. PMID 21425970 DOI: 10.4155/Fmc.09.22 |
0.787 |
|
| 2009 |
Hassan HE, Mercer SL, Cunningham CW, Coop A, Eddington ND. Evaluation of the P-glycoprotein (Abcb1) affinity status of a series of morphine analogs: comparative study with meperidine analogs to identify opioids with minimal P-glycoprotein interactions. International Journal of Pharmaceutics. 375: 48-54. PMID 19481690 DOI: 10.1016/J.Ijpharm.2009.03.037 |
0.779 |
|
| 2008 |
Mercer SL, Cunningham CW, Eddington ND, Coop A. Opioids and efflux transporters. Part 3: P-glycoprotein substrate activity of 3-hydroxyl addition to meperidine analogs. Bioorganic & Medicinal Chemistry Letters. 18: 3638-40. PMID 18499452 DOI: 10.1016/J.Bmcl.2008.04.046 |
0.783 |
|
| 2008 |
Cunningham CW, Mercer SL, Hassan HE, Traynor JR, Eddington ND, Coop A. Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs. Journal of Medicinal Chemistry. 51: 2316-20. PMID 18311899 DOI: 10.1021/Jm701457J |
0.798 |
|
| 2007 |
Mercer SL, Hassan HE, Cunningham CW, Eddington ND, Coop A. Opioids and efflux transporters. Part 1: P-glycoprotein substrate activity of N-substituted analogs of meperidine. Bioorganic & Medicinal Chemistry Letters. 17: 1160-2. PMID 17251015 DOI: 10.1016/J.Bmcl.2006.12.042 |
0.769 |
|
| 2006 |
Cunningham CW, Thatcher LN, Coop A. Methylation of non-acidic alcohols of alkaloids with TMS-diazomethane: Conversion of codeine to codeine-6-methyl ether Heterocycles. 68: 837-840. DOI: 10.3987/Com-06-10694 |
0.428 |
|
| 2006 |
Cunningham CW, Coop A. Therapeutic applications of opioid antagonists Chimica Oggi. 24: 54-57. |
0.7 |
|
| Show low-probability matches. |
